BOSTON, April 08, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology firm devoted to discovering and creating transformative therapies to revive and enhance listening to and steadiness, in the present day introduced that Laurence Reid, Ph.D., Chief Govt Officer of Decibel, will current on the Needham Digital Healthcare Convention on Thursday, April 15, 2021 at 4:30 pm ET.
A stay webcast of the presentation could also be accessed by visiting the Buyers and Media part of the Decibel Therapeutics web site at https://ir.decibeltx.com. An archived replay of the webcast can be accessible on the Firm’s web site for about 90 days following the presentation.
About Decibel Therapeutics
Decibel Therapeutics is a clinical-stage biotechnology firm devoted to discovering and creating transformative therapies to revive and enhance listening to and steadiness, one of many largest areas of unmet want in medication. Decibel has constructed a proprietary platform that integrates single-cell genomics and bioinformatic analyses, precision gene remedy applied sciences and experience in inside ear biology. Decibel is leveraging its platform to advance gene therapies designed to selectively change genes for the therapy of congenital, monogenic listening to loss and to regenerate inside ear hair cells for the therapy of acquired listening to and steadiness issues. Decibel’s pipeline, together with its lead gene remedy program, DB-OTO, to deal with congenital, monogenic listening to loss, is designed to ship on our imaginative and prescient of a world wherein the privileges of listening to and steadiness can be found to all.
Stern Investor Relations, Inc.
Ten Bridge Communications